Novartis has bulked up its cardiology pipeline with a $1.4 billion takeover of Tourmaline Bio and its phase 3-ready drug for atherosclerotic cardiovascular disease (ASCVD). The Swiss pharma group has ...

I’m Lauren Paige Richeson, an editor at Health. Since 2022, I have been writing, editing, and producing expert-driven health content. With a background in biology and over a decade of experience in ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness myths. On my spare time I enjoy cooking ...

Unsurprisingly, one of the first things the Peloton instructors recommend buying is a bike. “To be fair, I get on my bike most mornings!” says Frankson, who’s known for her upbeat cycling classes.

To my surprise, I've still not gone back to the gym five years later. Over that time, I’ve invested in some really effective ...